CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS
P. Lissoni et al., CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS, Journal of biological regulators and homeostatic agents, 10(2-3), 1996, pp. 60-62
Despite its well documented unfavourable prognostic significance in se
veral human diseases, including cancer, the cytokinic mechanisms respo
nsible for an increased erythrosedimentation rate (ESR) still remain t
o be better analyzed and defined The recent possibility to measure cyt
okine concentrations in the blood of patients has allowed us to explor
e the possible relation between ESR values and endogenous cytokine sec
retions. This preliminary study was performed to evaluate the relation
ship between ESR values and serum levels of IL-2 and IL-6, which repre
sent the most important cytokines responsible for the activation and t
he suppression, respectively, of host anticancer immune reaction. The
study included 33 consecutive solid tumor patients, 22 of whom showed
distant organ metastases. Abnormally high values of ESR were present i
n 21 patients, including 18/22 metastatic patients and 3/11 nonmetasta
tic patients. Patients with elevated values of ESR showed significantl
y higher mean levels of IL-6 and significantly lower mean concentratio
ns of IL-2 with respect to those found in patients with normal ESR val
ues. These results would show that cancer-related increase in ESR valu
es is associated with low levels of IL-2 and high levels of IL-6. Sinc
e IL-2 plays an essential role in the anticancer immunity and IL-6 may
suppress the antitumor immune defenses, the evidence of low levels of
IL-2 and high values of IL-6 in cancer patients with increased ESR va
lues would explain the unfavourable prognostic significance of high ES
R values in human neoplasms.